Notice: This company has been marked as potentially delisted and may not be actively trading. Adamas Pharmaceuticals (ADMS) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Why did the Raiders trade Davante Adams? Drama, contract lead to Jets dealOctober 16, 2024 | usatoday.comGlancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Adamas Pharmaceuticals, Inc. - ADMSMay 13, 2024 | prnewswire.comSurvalent, Electroval win bid to provide ICE "first of its kind" ADMS and DERMS platformApril 7, 2023 | benzinga.comAdvanced Distribution Management Systems (ADMS) Market 2023 | Global Industry Report Forecast 2029April 7, 2023 | marketwatch.comAdvanced Distribution Management Systems (ADMS) Market LATEST REPORT 2023 to 2030March 30, 2023 | marketwatch.comAdamas One Corp (JEWL)March 3, 2023 | investing.com2023 Advanced Distribution Management System (ADMS) Market: Top Growing Regions for Business Leaders by 2029March 1, 2023 | marketwatch.comAdvanced Distribution Management System (ADMS) Market 2023 | Global Industry Report Forecast 2029March 1, 2023 | marketwatch.comAdvanced Distributed Management System (ADMS) Market Is Booming Worldwide Forecast 2023-2029February 24, 2023 | marketwatch.comAdvanced Distribution Management Systems (ADMS) Market Future Trends Demand 2023, and Forecast to 2029January 14, 2023 | marketwatch.com8 Stocks to Buy According to Devesh Gandhi’s SilverArc CapitalMay 25, 2022 | insidermonkey.comSupernus Pharmaceuticals Completes Acquisition of Adamas PharmaceuticalsNovember 24, 2021 | finance.yahoo.comTrading was temporarily halted for "ADMS" at 07:11 PM with a stated reason of "News pending."November 24, 2021 | marketbeat.comSupernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call TranscriptNovember 4, 2021 | finance.yahoo.comHow Much Of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Do Institutions Own?November 2, 2021 | finance.yahoo.comEast Bay drug maker's potential sale brings lawsuits, job cutsNovember 1, 2021 | bizjournals.comWill Adamas Pharmaceuticals (ADMS) Report Negative Q3 Earnings? What You Should KnowOctober 28, 2021 | finance.yahoo.comADAMAS ALERT: Bragar Eagel & Squire, P.C. Announces Commencement of Tender Offer and Encourages Investors to Contact the FirmOctober 27, 2021 | finance.yahoo.comWhy Supernus' Acquisition of Adamas Is a Smart MoveOctober 21, 2021 | finance.yahoo.comSHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing InvestigationsOctober 18, 2021 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, AZPN, GSKY, GWB; Shareholders are Encouraged to Contact the FirmOctober 18, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Adamas Pharmaceuticals, Inc. - ADMSOctober 16, 2021 | prnewswire.comSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Adamas Pharmaceuticals, Inc. - ADMSOctober 15, 2021 | finance.yahoo.comADAMAS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ADMS and Encourages Investors to Contact the FirmOctober 14, 2021 | finance.yahoo.comADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas ...October 13, 2021 | businesswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Adamas Pharmaceuticals, Inc. MergerOctober 12, 2021 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, AZPN, CXP; Shareholders are Encouraged to Contact the FirmOctober 12, 2021 | finance.yahoo.comAdamas Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Adamas Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to ...October 11, 2021 | businesswire.comSHAREHOLDER ALERT: WeissLaw LLP Investigates Adamas Pharmaceuticals, Inc.October 11, 2021 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Adamas Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with SupernusOctober 11, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Adamas Pharmaceuticals, Inc. with Supernus Pharmaceuticals, Inc.October 11, 2021 | finance.yahoo.comMid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas PharmaceuticalsOctober 11, 2021 | markets.businessinsider.comSupernus bolsters Parkinson's portfolio with $400 mln deal for Adamas PharmaOctober 11, 2021 | reuters.comADMS Stock Soars 70% Thanks to Adamas Pharmaceuticals Acquisition NewsOctober 11, 2021 | msn.comUPDATE 3-Supernus bolsters Parkinson's portfolio with $400 mln deal for Adamas PharmaOctober 11, 2021 | finance.yahoo.comAdamas Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Adamas Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ADMSOctober 11, 2021 | finance.yahoo.comFlexion and Adamas Surge. The Small-Cap Pharma Firms Are Being Acquired.October 11, 2021 | finance.yahoo.comUPDATE 1-Supernus to buy Adamas Pharma for about $400 mlnOctober 11, 2021 | msn.comSupernus Pharma To Acquire Adamas Pharma For Total Consideration Up To $9.10/shrOctober 11, 2021 | nasdaq.comSupernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product PortfolioOctober 11, 2021 | finance.yahoo.comAdamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health AwardsOctober 1, 2021 | finance.yahoo.comAdamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society's (MDS) CongressSeptember 18, 2021 | stockhouse.comAdamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) CongressSeptember 16, 2021 | finance.yahoo.comAdamas Announces New Employment Inducement GrantsSeptember 10, 2021 | finance.yahoo.comLooking Into Adamas Pharmaceuticals's Return On Capital EmployedSeptember 10, 2021 | benzinga.comAdamas to Present at Upcoming September Investor ConferencesAugust 30, 2021 | finance.yahoo.comAdamas Pharmaceuticals Inc (ADMS) Q2 2021 Earnings Call TranscriptAugust 10, 2021 | finance.yahoo.comAdamas Pharmaceuticals earnings preview: what Wall Street is expectingAugust 9, 2021 | markets.businessinsider.comAdamas Pharmaceuticals (ADMS) Reports Q2 Loss, Lags Revenue EstimatesAugust 9, 2021 | nasdaq.comAdamas Reports Second Quarter 2021 Financial ResultsAugust 9, 2021 | finance.yahoo.com Get Adamas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Top secret Trump trades? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today ADMS Media Mentions By Week ADMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMS News Sentiment▼0.000.51▲Average Medical News Sentiment ADMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMS Articles This Week▼00▲ADMS Articles Average Week Get Adamas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SDGR News INDV News TVTX News SYRE News PRAX News DAWN News OCUL News SNDX News RCUS News SPRY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMS) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adamas Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adamas Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
